Question to the Department of Health and Social Care:
To ask Her Majesty's Government what assessment they have made of whether supplies of immunoglobin are sufficient to meet current demand; and what steps they are taking to ensure that all patients can be maintained on the therapy they need.
At the start of the COVID-19 pandemic, NHS England and NHS Improvement’s national commissioning criteria for the use of therapeutic immunoglobulin provided expert guidance for the management of patients on immunoglobulin treatment. There is a demand management plan available for use as a contingency to address any instance of constrained supply.
At present, supplies of immunoglobulin are available for patients who require it. An updated demand management plan is currently being developed with updated commissioning criteria to ensure immunoglobulin remains accessible.